Myocardial revascularization: guideline-based therapy today

Myocardial revascularization.

Angiogenesis by gene therapy: a new horizon for myocardial revascularization?

The concept of therapeutic angiogenesis is based on the premise that the potential for vascular growth inherent in vascular tissue can be utilized to promote the development of new blood vessels under the influence of the appropriate growth factors. Direct application of growth factors of the fibroblast (acidic, basic fibroblast growth factor, FGF-5), endothelial (vascular endothelial growth fa...

Myocardial laser revascularization.

Some patients with severe angina have coronary artery disease which is unsuitable for conventional forms of revascularization — coronary angioplasty/ stenting or coronary artery bypass surgery. These patients have usually undergone previous revascularization procedures and have disease which is diffuse and affects the distal part of the coronary circulation. Transmyocardial laser revascularizat...

Anesthesia for Myocardial Revascularization

Providing anesthesia care for patients undergoing coronary artery bypass grafting (CABG) continues to be a challenging yet rewarding endeavor. Surgical, anesthetic, and technologic advances continue to drive changes in clinical routines at a rapid pace, even at a time when the numbers of cases have declined because of the growth of percutaneous coronary interventions (PCIs). Cardiac anesthesiol...

Emergency myocardial revascularization.

From 1969 to 1975, 175 patients with acute coronary insufficiency underwent emergency saphenous vein aorto-coronary bypass grafting (SVBG). The patients were divided into two groups: group I, unstable angina (165 patients) and group II, acute evolving myocardial infarction (ten patients). In group I, the hospital mortality was 8-4%, the incidence of post-operative myocardial infarction was 10-3...